Cytochrome P450 and Anticancer Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|7|1|23-37

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.7, Iss.1, 2006-01, pp. : 23-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450 3A polymorphisms and immunosuppressive drugs

By Thervet Eric   Legendre Christopher   Beaune Philippe   Anglicheau Dany  

Pharmacogenomics, Vol. 6, Iss. 1, 2005-01 ,pp. : 37-47

Future Medicine

Access to resources Recommend Favorite

“Drugs on oxygen”: an update and perspective on the role of cytochrome P450 testing in pharmacology

By Tralau Tewes   Luch Andreas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1357-1362

Informa Healthcare

Access to resources Recommend Favorite

Prediction of Cytochrome P450 Mediated Metabolism of Designer Drugs

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 11, 2014-06 ,pp. : 1365-1373

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs

By Zhou Shufeng  

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 279-304

Adis International

Access to resources Recommend Favorite

Chromatographic Determination of Drugs and Their Metabolites for Phenotyping Cytochrome P-450 Isoenzymes

By Ramenskaya G.  

Pharmaceutical Chemistry Journal, Vol. 39, Iss. 2, 2005-02 ,pp. : 108-111

Springer Publishing Company

Access to resources Recommend Favorite